Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity

Published:2022-01-10 Issue:2 Volume:6 Page:129-143
ISSN:2157-846X
Container-title:Nature Biomedical Engineering
language:en
Short-container-title:Nat Biomed Eng

Author:

Agarwal Yash^ORCID,Milling Lauren E.,Chang Jason Y. H.^ORCID,Santollani Luciano,Sheen Allison,Lutz Emi A.^ORCID,Tabet Anthony,Stinson Jordan,Ni Kaiyuan,Rodrigues Kristen A.^ORCID,Moyer Tyson J.,Melo Mariane B.^ORCID,Irvine Darrell J.^ORCID,Wittrup K. Dane^ORCID

Funder

Ludwig Center at the MIT KI.

Thomas and Stacey Siebel Foundation

Marble Center for Nanomedicine

NSF | Directorate for Education & Human Resources | Division of Graduate Education

Alfred P. Sloan Foundation

Paul and Daisy Soros Fellowships for New Americans

Howard Hughes Medical Institute

Publisher

Springer Science and Business Media LLC

Subject

Computer Science Applications,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology

Link

https://www.nature.com/articles/s41551-021-00831-9.pdf

Reference69 articles.

1. Wolchok, J. D. et al. Overall survival with combined nivolumab and ipilimumab in advanced melanoma. N. Engl. J. Med. 377, 1345–1356 (2017).

2. Ansell, S. M. et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N. Engl. J. Med. 372, 311–319 (2015).

3. Brahmer, J. et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N. Engl. J. Med. 373, 123–135 (2015).

4. Bellmunt, J. et al. Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N. Engl. J. Med. 376, 1015–1026 (2017).

5. Yi, M. et al. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors. Mol. Cancer 17, 129 (2018).

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A natural adhesive-based nanomedicine initiates photothermal-directed in situ immunotherapy with durability and maintenance;Biomaterials;2025-01

2. Engineered nano-aluminum adjuvant for cancer immunotherapy: Progress, challenges and opportunities towards preclinical/clinical application;Coordination Chemistry Reviews;2024-11

3. Immunomodulatory metal-based biomaterials for cancer immunotherapy;Journal of Controlled Release;2024-11

4. Production and evaluation of three kinds of vaccines against largemouth bass virus, and DNA vaccines show great application prospects;Fish & Shellfish Immunology;2024-10

5. Bioactive metal-based nanomedicines for boosting anti-tumor immunity: Advance, challenge, and perspective;Coordination Chemistry Reviews;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3